Awaiting product image

Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma

€3.03

SKU: product-article-17987 Category:

Description

Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma

Reviews

There are no reviews yet.

Be the first to review “Article: Three-year follow-up data of ELOQUENT-2: sustained benefit of elotuzumab in patients with relapsed/ refractory multiple myeloma”

Related products